Development and technical services for the NCI applied research program

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200644006C
Awardee
Awarding agency
Obligated
$7,174,637

Award facts

Opportunity
Contract value 17% obligated
  • $7,174,636.94 Current, with exercised options
  • $41,827,930.94 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 18 -$22,454
Other Administrative Action 17 -$21,769
Other Administrative Action 16 $0
Other Administrative Action 15 $0
Other Administrative Action 14 $0
Other Administrative Action 13 $0
Other Administrative Action 12 $0
Change Order 11 $141,581
Exercise an Option 10 · Other functions to change the principal investigator $290,569
Other Administrative Action 9 · To change the principal investigator $0
Exercise an Option 8 · Other functions to exercise option year 1 for the development and technical services for the NCI applied research program $280,892
Supplemental Agreement for work within scope 7 $148,563
Supplemental Agreement for work within scope 6 · Arra::yes::arra recovery act development and technical services for the NCI applied research program $2,457,255
Modification 3 $650,000
Modification 4 $650,000
Modification 1 $650,000
Modification $650,000
Modification 2 $650,000
Original award 5 $650,000
Show all 19

About this award

This federal contract award, valued at $41,827,930.94, was issued by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, which has no set-aside designation, is for the "DEVELOPMENT AND TECHNICAL SERVICES FOR THE NCI APPLIED RESEARCH PROGRAM" and has an ultimate completion date of August 31, 2014.

Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies, particularly in the areas of public health, education, transportation, and social policy. For the NCI, Westat has supported cancer clinical trials, offering services such as site study setup, protocol writing, and electronic patient-reported outcomes collection. The company also holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $320 million IDV with the NCI for field and biospecimen support services, and a $548 million IDV for the Cancer Trials Support Unit, providing broad-based support for cancer clinical trials.

Quick answers

Who was awarded contract HHSN261200644006C?

HHSN261200644006C was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2006.

How much is contract HHSN261200644006C worth?

The government has obligated $7,174,637 on HHSN261200644006C. Its potential value, with all options, is $41,827,931.

Was contract HHSN261200644006C competed?

The extent of competition for HHSN261200644006C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award